IUPAC/Chemical Name
N-(alpha, alpha, alpha-Trifluoro-m-tolyl)anthranilic acid, ester with glycolamide.
InChi Key
QNIUBYBLEIJTNS-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H13F3N2O3/c17-16(18,19)10-4-3-5-11(8-10)21-13-7-2-1-6-12(13)15(23)24-9-14(20)22/h1-8,21H,9H2,(H2,20,22)
SMILES Code
O=C(N)COC(C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
338.29
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Wilder PT, Weber DJ, Winstead A, Parnell S, Hinton TV, Stevenson M, Giri D, Azemati S, Olczak P, Powell BV, Odebode T, Tadesse S, Zhang Y, Pramanik SK, Wachira JM, Ghimire S, McCarthy P, Barfield A, Banerjee HN, Chen C, Golen JA, Rheingold AL, Krause JA, Ho DM, Zavalij PY, Shaw R, Mandal SK. Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA- MB-231 breast cancer cells. Mol Cell Biochem. 2018 Apr;441(1-2):151-163. doi: 10.1007/s11010-017-3181-z. Epub 2017 Sep 14. PMID: 28913709; PMCID: PMC7191999.
2: Atassi F, Byrn SR. General trends in the desolvation behavior of calcium salts. Pharm Res. 2006 Oct;23(10):2405-12. doi: 10.1007/s11095-006-9015-4. Epub 2006 Aug 23. PMID: 16927185.
3: Hawksworth EL, Andrews PC, Lie W, Lai B, Dillon CT. Biological evaluation of bismuth non-steroidal anti-inflammatory drugs (BiNSAIDs): stability, toxicity and uptake in HCT-8 colon cancer cells. J Inorg Biochem. 2014 Jun;135:28-39. doi: 10.1016/j.jinorgbio.2014.02.012. Epub 2014 Mar 1. PMID: 24650572.
4: Pribová M, Gregorová J, Drsata J. Inhibition of aromatic amino acid decarboxylase by a group of non-steroidal anti-inflammatory drugs. Pharmacol Res. 1992 Apr;25(3):271-7. doi: 10.1016/s1043-6618(05)80076-3. PMID: 1518771.
